Skip to main content
SYNLAB AG logo

SYNLAB AG — Investor Relations & Filings

Ticker · SYAB ISIN · DE000A2TSL71 LEI · 984500883BA5AQ14C037 F Human health and social work activities
Open in API
Filings indexed 152 across all filing types
Latest filing 2026-03-31 Regulatory Filings
Country DE Germany
Listing F SYAB

About SYNLAB AG

https://www.synlab.com/

SYNLAB AG is a leading provider of medical laboratory diagnostic services. The company offers a comprehensive portfolio of over 5,000 routine and specialty tests across various medical disciplines, including human genetics and anatomical pathology. Its services provide essential diagnostic information for doctors, clinics, and patients, playing a vital role in clinical decision-making throughout the entire patient care process, from prevention and diagnosis to treatment and monitoring.

Recent filings

Filing Released Lang Actions
Region Stockholm engages SYNLAB to expand its medical diagnostic services in Sweden
Regulatory Filings Classification · 85% confidence The document is a corporate press release announcing that Region Stockholm has awarded SYNLAB a service contract to expand its medical diagnostic services. It does not present financial results or detailed financial statements, nor is it a formal report (10-K, IR, etc.), an earnings release, or an SEC-style filing. It is a general corporate news/regulatory announcement. Therefore, it falls under the fallback category of Regulatory Filings (RNS).
2026-03-31 English
Further investment in Italy to provide cutting-edge diagnostics and patient experience
Regulatory Filings Classification · 100% confidence The document is a corporate news release issued by SYNLAB regarding a strategic investment in medical diagnostic technology (a photon-counting CT scanner) in Italy. It does not report financial results, board changes, or regulatory filings, but rather serves as a press release/corporate announcement regarding company operations and strategic initiatives. As it does not fit into specific categories like 10-K, ER, or M&A, it falls under the general regulatory/corporate news category.
2025-10-23 English
SYNLAB expands investment in Italy with opening of flagship Medical Centre in Florence
Regulatory Filings Classification · 100% confidence The document is a corporate press release announcing the opening of a new medical centre in Florence. It does not contain financial statements, regulatory filings, or specific shareholder meeting materials. As it is a general corporate news announcement regarding business expansion, it falls under the 'Regulatory Filings' (RNS) category, which serves as the fallback for general corporate news and announcements that do not fit into more specific categories like M&A or Earnings Releases.
2025-10-09 English
Datum:31.07.2025
Legal Proceedings Report Classification · 99% confidence The document is a formal legal notice regarding a 'Verlustübernahmeverpflichtung' (loss absorption obligation) under German commercial law (HGB and AktG). It details the parent company's commitment to cover losses for its subsidiaries. This is a specific regulatory disclosure required under German corporate law for consolidated financial reporting purposes. Since it does not fit into standard categories like earnings releases, annual reports, or shareholder voting results, it falls under the 'Regulatory Filings' category.
2025-07-31 German
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.01.2023 bis zum 30.06.2023
Legal Proceedings Report Classification · 99% confidence The document is a formal legal declaration by SYNLAB AG regarding a 'Verlustübernahmeverpflichtung' (loss absorption obligation) under German commercial law (§ 264 Abs. 3 HGB and § 302 Abs. 1 AktG). It lists various subsidiaries and confirms the parent company's commitment to cover losses for the specified fiscal period. This is a regulatory disclosure required by German corporate law for consolidated financial reporting purposes, which does not fit into standard financial reporting categories like 10-K or IR, nor is it a simple announcement. Therefore, it is classified as a Regulatory Filing.
2025-07-31 German
Study Findings Reveal: Gut Microbiome May Offer Early Insight into Dementia Risk
Regulatory Filings Classification · 95% confidence The document is a short news release dated July 22, 2025, announcing study findings related to the gut microbiome and dementia risk, involving an expert from SYNLAB AG. It is not a formal regulatory filing like a 10-K, IR, or ER, as it focuses on research results rather than financial performance or mandatory disclosures. The text explicitly states it is a 'News Details' item and mentions the dissemination service (EQS News) which handles various announcements. Since it is an announcement of research/study results and does not fit the specific categories like Earnings Release (ER), Audit Report (AR), or Environmental/Social Report (SR), it falls best under the general 'Regulatory Filings' (RNS) category, which serves as a fallback for general corporate news releases that aren't covered by more specific codes. The length is moderate (6639 chars), but the content is purely informational news, not a comprehensive report.
2025-07-22 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.